Generic immunizing agent - 29061000087103
View generic immunizing agent subset
Concept details
[COVID-19] Non-replicating vector COVID-19 vaccine
Pan-Canadian SNOMED CT terminology
- Concept code
- 29061000087103
- Concept status
- active
- Version
- 20210930
- Display name
- English: [COVID-19] Non-replicating vector COVID-19 vaccine
- French: [COVID-19] vaccin à vecteur viral non réplicatif contre la COVID-19
- Abbreviation
- English: COVID-19
- French: COVID-19
- Fully specified name
- Vaccine product containing only recombinant non-replicating viral vector encoding severe acute respiratory syndrome coronavirus 2 spike protein (medicinal product)
Health Canada drug information
Product status
- Authorization By Interim Order Expired
- Cancelled Post Market
Linked concepts
Linked tradename concept(s)
This vaccine protects against the following diseases:
This vaccine contains the following antigens:
National Vaccine Catalogue database details
- Last updated
- 2025-03-06
Concept history
This concept replaces
| Concept code | Display name |
|---|---|
| No data is available | |
Notice
Some information normally contained in the National Vaccine Catalogue may be unavailable due to ongoing mapping updates or because the source data did not provide the information, and in some cases, the information field is blank as it may not be applicable in the given context. The information contained in the National Vaccine Catalogue may also be subject to change following data reconciliation.
Disclaimer
The use of the standard SNOMED CT terminology and codes is subject to your annual acceptance of both the SNOMED CT® Affiliate License Agreement and the SNOMED CT® Canadian National License Agreement. To acknowledge and accept these agreements, register an account on Canada Health Infoway. For additional information on the agreements, please visit Canada Health Infoway.
- Version:
- 1.0.12